drugset / Trial / NCT04424602

Comparison between2 Drugs in Lupus Nephritis

NCT04424602

Phase 4 Completed 40 enrolled Al-Azhar University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this work is to study the effect and side effects of the cyclophosphamide versus mycophenolate in lupus nephritis

Timeline

Start
2021-04-05
Primary completion
2021-09-05
Completion
2021-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 500 mg Intravenous
Comparator Mycophenolate Sodium Unknown 2 mg/kg Oral
Comparator Mycophenolate Sodium Unknown 3 mg/kg Oral

Indications